“Cost Of Illness” Analysis Of Chronic Kidney Disease In The Entire Population Of The Russian Federation

Abstract

A187 patients was CNY159722, in patients with peritoneal dialysis for CNY96739; In CKD patients, the presence of acute onset of CVD events, no acute CVD events and patients without CVD showed that the medical costs for three groups of median were CNY38211.9 (11 685.1~73 358.7), ll061.4 (3 809.0 ~ 23 241.0) and 13678.7 (456.5 ~36 995.3).The indirect economic burden included loss of time and property in patients because of illness. In hemodialysis patients, per capita annual indirect costs were CNY27531.2. In peritoneal dialysis patients, per capita annual indirect costs were CNY96739.6. ConClusions: Economic Burden of chronic kidney disease patients with hyperphosphatemia is "catastrophic expenses" for the vast majority of the patient's families. In order to protect the interests of patients, health insurance in China needs to constantly change the protection's structures, improve the ability of insurance and expand the range of coverage.